Plant-Based Meals for Multiple Myeloma
Trial Summary
What is the purpose of this trial?
This clinical trial evaluates the impact of a plant-based whole-foods delivery service on the microbiome in patients with multiple myeloma undergoing an autologous hematopoietic cell transplant. An autologous hematopoietic cell transplant is a procedure in which blood-forming stem cells (cells from which all blood cells develop) are removed, stored, and later given back to the same person. Loss of microbial diversity within the intestinal tract has been associated with poor outcomes for patients receiving autologous stem cell transplantation. A plant-based whole meal delivery service may increase the intake of foods high in fiber and nutrients therefore improve microbial health during the peri-transplant period. In this pilot study, study investigators will explore the feasibility of this approach.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on diet changes, so you may not need to stop your medications, but it's best to check with the trial organizers.
What evidence supports the effectiveness of a plant-based diet for treating multiple myeloma?
Research suggests that people who follow a plant-based diet, such as vegetarians and vegans, may have a lower risk of developing multiple myeloma compared to those who eat meat. Additionally, a diet high in fruits, vegetables, and whole grains is recommended for cancer survivors to improve quality of life.12345
Is a plant-based diet safe for humans?
Plant-based diets, including vegan and vegetarian diets, are generally safe and can be nutritionally sufficient if well-planned. However, poorly-designed plant-based diets may lead to deficiencies in nutrients like vitamin B12, iron, and calcium, so it's important to ensure a balanced intake of essential nutrients.16789
How does a plant-based diet differ from other treatments for multiple myeloma?
A plant-based diet is unique because it focuses on nutrition and lifestyle changes rather than medication, aiming to improve overall health and potentially influence cancer progression through increased intake of fruits, vegetables, and whole grains. This approach is different from standard treatments that typically involve chemotherapy or other drug therapies.310111213
Research Team
Kate Markey
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Eligibility Criteria
This trial is for patients with multiple myeloma who are undergoing an autologous hematopoietic cell transplant. The study aims to see if a plant-based whole-foods meal delivery can improve their gut microbiome, which is important for health during the transplant process.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Peri-transplant
Participants receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Blood and stool samples are collected.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of meal tolerability and collection rates.
Treatment Details
Interventions
- Plant-Based Whole-Foods Meal Delivery Service
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Center
Lead Sponsor
Swim Across America
Collaborator
Swim Across America
Collaborator